NICE on lipid modification: NICE's simplified approach to lipids will not work

Comment

Stuart J Laurie. BMJ. 2008.

. 2008 Jun 14;336(7657):1324.

doi: 10.1136/bmj.39605.513889.3A.

No abstract available

Conflict of interest statement

Competing interests: None declared.

NICE on lipid modification: NICE's simplified approach can't not work.
Hird MI. Hird MI. BMJ. 2008 Jun 28;336(7659):1454. doi: 10.1136/bmj.39619.524907.3A. BMJ. 2008. PMID: 18583659 Free PMC article. No abstract available.

Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis.
Law MR, Wald NJ, Rudnicka AR. Law MR, et al. BMJ. 2003 Jun 28;326(7404):1423. doi: 10.1136/bmj.326.7404.1423. BMJ. 2003. PMID: 12829554 Free PMC article.
Risk assessment and lipid modification for primary and secondary prevention of cardiovascular disease: summary of NICE guidance.
Cooper A, O'Flynn N; Guideline Development Group. Cooper A, et al. BMJ. 2008 May 31;336(7655):1246-8. doi: 10.1136/bmj.39554.624086.AD. BMJ. 2008. PMID: 18511800 Free PMC article. Review. No abstract available.

1. Cooper A, O’Flynn N, on behalf of the Guideline Development Group. Risk assessment and lipid modification for primary and secondary prevention of cardiovascular disease: summary of NICE guidance. BMJ 2008;336:1246-8. (31 May.) - PMC - PubMed
1. Law MR, Wald NJ, Rudnicka AR. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. BMJ 2003;326:1407-8. - PMC - PubMed
1. Cheshire and Merseyside Cardiac Network. Guidelines for the use of statins in secondary prevention of cardiovascular disease and in patients with type 2 diabetes. January 2005. www.cmcn.nhs.uk/document_uploads/Guidelines/CMCN%20Statin%20guidelines%2...